Haploidentical transplantation using low‐dose alemtuzumab: Comparison with haploidentical transplantation using low‐dose thymoglobulin - Concepedia

Concepedia

Publication | Closed Access

Haploidentical transplantation using low‐dose alemtuzumab: Comparison with haploidentical transplantation using low‐dose thymoglobulin

15

Citations

27

References

2018

Year

Shinichi Kako, Ayumi Gomyo, Yu Akahoshi, Naonori Harada, Kazuaki Kameda, Tomotaka Ugai, Hidenori Wada, Yuko Ishihara, Koji Kawamura, Kana Sakamoto,

European Journal Of Haematology

Abstract

Haploidentical HSCT using low-dose alemtuzumab can be performed safely. We need to overcome the high relapse/progression rate in non-remission patients.

References

	Year	Citations

Page 1